ATYR Pharma has been in the spotlight after its recent trial results shook investor confidence. The company, once seen as a promising name in biotech, has faced challenges that directly impacted its stock performance. For investors, the key question now is whether ATYR stock should be sold, held, or bought during this uncertain phase. A